ArticleNuclear medicine and biology
Development of [
Article in Nuclear medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 29 citations in OpenAlex.
- Triarylselenonium triflates provide efficient access to no-carrier-addedChemical science · 2026Article
- [Novel imaging techniques for the differential diagnosis of adrenal tumors, pheochromocytomas and paragangliomas].Chirurgie (Heidelberg, Germany) · 2026Review
- Emerging methods for subtype differentiation in primary aldosteronism.Journal of internal medicine · 2026Review
- Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks.Endocrine reviews · 2024Article
- Advances in the molecular imaging of primary aldosteronism.Annals of nuclear medicine · 2023Review
- Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022Article
- Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms.Frontiers in oncology · 2022Review
- Development of [Journal of medicinal chemistry · 2021Article
- Para-chloro-2-[International journal of medical sciences · 2021Article
- Adrenal Incidentaloma.Endocrine reviews · 2020Review
- Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism.JAMA network open · 2020Article
- Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.Current hypertension reports · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
introductionPrimary aldosteronism accounts for 6-15% of hypertension cases, the single biggest contributor to global morbidity and mortality. Whilst ~50% of these patients have unilateral aldosterone-producing adenomas, only a minority of these have curative surgery as the current diagnosis of unilateral disease is poor. Carbon-11 radiolabelled metomidate ([
methodsTwo strategies for the one-step radio-synthesis of [
results[
conclusions[
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.